Cancer Science · 2018 · 48 citations · 23 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyMalignant NeoplasmsMyeloid-derived Suppressor CellsTumor ImmunopathologyEffector T Cell ActivationGranulocytic Myeloid-derived Suppressor CellsMonocytic Myeloid-derived Suppressor CellsMyeloid-derived Suppressor Cell FunctionMyeloid-derived Suppressor Cell ImmunosuppressionMyeloid-derived Suppressor Cell ModulationMyeloid-derived Suppressor Cell-mediated SuppressionSuppressor Cell Biology
Myeloid‐derived suppressor cells ( MDSC ) are a heterogeneous population of immature myeloid cells which consist of 2 subsets: granulocytic MDSC (G‐ MDSC ) and monocytic MDSC (M‐ MDSC ). MDSC expand in tumor‐bearing hosts and contribute to immunotherapeutic resistance by remarkably blocking effector T‐cell activation via different mechanisms. Resveratrol ( RSV ) is a polyphenol and it has been widely used for its various health benefits. However, the underlying mechanism of its anti‐tumor properties remains unclear. In this study, a transplantable mouse model was used to investigate the effects of RSV on MDSC . The results showed that RSV ameliorated tumor development by decreasing G‐ MDSC accumulation, impairing its suppressive ability on CD 8 + T cells and promoting M‐ MDSC differentiation into CD 11c + and F4/80 + cells. Our results indicated that RSV should be considered as a modular of MDSC suppressive function and that RSV is a novel booster for tumor immunotherapy.
23
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
Minu K. Srivastava, Li Zhu, Marni E. Harris‐White et al. · PLoS ONE · 2012 · 220 citations · Full text
Medicine, Immunology, Oncology +17
Narendra P. Singh, Venkatesh L. Hegde, Lorne J. Hofseth et al. · Molecular Pharmacology · 2007 · 172 citations · Full text